Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Baclofen for alcohol use disorder with EEG beta activity assessment
ACTRN12613000372785Phase 4Not yet recruiting
- Sponsor
- Royal Adelaide Hospital
- Start
- Jun 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of baclofen in alcohol use disorder (AUD), sponsored by Royal Adelaide Hospital. Primary endpoint: Amount of high-frequency beta activity on quantitative electroencephalogram. Planned start Jun 2013; status: not yet recruiting.
02
Drugs
baclofen
03
Conditions
alcohol use disorder (AUD)
Beyond the preview
Go deeper on ACTRN12613000372785.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12613000372785.